Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice

Table 3 Treatments administered during PDSS events in routine clinical practice

Treatment	Percentage of cases ^a
No treatment	19 (47/243)
Medication	31 (75/243)
Potentially sedative drug	19 (45/243)
Intravenous fluids	25 (60/243)
Monitoring	21 (51/243)
Oxygen	5 (13/243)
Physical restraint	4 (9/243)
Admission to intensive care unit	18 (44/243)
Ventilation/intubation	5 (13/243)

The table shows the treatment requirements for PDSS in the 243 cases where treatment data were available from two post-marketing safety studies and spontaneous reports.
^aSome cases involved more than one type of treatment, and are therefore included more than once in the table.
PDSS = post-injection delirium/sedation syndrome.

ISSN: 1471-244X